HealthTab™ Adds ID NOW™ Molecular Test Device to Abbott Distribution Agreement, Now Offers First Real-Time Reporting of SARS-CoV-2, Flu, Strep and RSV System in Pharmacy
VANCOUVER, BC – (GLOBE NEWSWIRE) – July 26, 2021 – Avricore Health Inc. (TSXV:AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of the first amendment to its supplier distribution agreement between HealthTab™ Inc., a wholly owned subsidiary, and Abbott, the global healthcare company and